Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents
- PMID: 26310808
- PMCID: PMC4617631
- DOI: 10.1161/ATVBAHA.115.306187
Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents
Figures
Comment on
-
Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1945-53. doi: 10.1161/ATVBAHA.115.305597. Epub 2015 Jul 16. Arterioscler Thromb Vasc Biol. 2015. PMID: 26183619 Free PMC article.
References
-
- Wang D, Deuse T, Stubbendorff M, Chernogubova E, Erben R, Eken S, Jin H, Li Y, Heeger C, Behnisch B, Reichenspurner H, Robbins R, Spin J, Tsao P, Schrepfer S, Maegdefessel L. Local microrna modulation using a novel anti-mir-21-eluting stent effectively prevents experimental in-stent restenosis. Arteriosclerosis, thrombosis, and vascular biology. 2015 - PMC - PubMed
-
- Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659–2673. - PubMed
-
- Alfonso F. Treatment of drug-eluting stent restenosis the new pilgrimage: Quo vadis? J Am Coll Cardiol. 2010;55:2717–2720. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
